DELCATH SYSTEMS, INC. DCTH
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2000-10-19
DELCATH SYSTEMS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 86.2% | 83.4% | 69.2% | 74.8% | 81.1% |
| Operating margin | 0.8% | -33.4% | -1849.0% | -1245.1% | -690.0% |
| Net margin | 3.2% | -70.9% | -2308.9% | -1342.7% | -721.5% |
| FCF margin | 24.6% | -51.7% | -1516.2% | -925.3% | -639.9% |
| Return on assets | 2.2% | -34.5% | -123.5% | -204.4% | -77.4% |
| Return on equity | 2.4% | -38.4% | -302.2% | 623.1% | -214.6% |
| Debt / equity | — | 0.00× | 0.64× | -2.68× | — |
| Current ratio | 10.92 | 12.01 | 2.26 | 1.10 | 5.23 |
| Revenue growth | 129.1% | 1701.7% | -24.1% | -23.5% | — |
Source: SEC EDGAR filings · CIK 0000872912 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.